Agents and Actions

, Volume 31, Issue 1–2, pp 157–163 | Cite as

Further studies on the antinociceptive effects ofΔ acid

  • S. A. Doyle
  • S. H. Burstein
  • W. L. Dewey
  • S. P. Welch
Pain and Analgesics


The antinociceptive effects ofΔ (THC-7-oic) acid have been investigated further with particular regard to the influence of certain experimental parameters in the hot plate test. These included the degree of the thermal stimulus, the nature of the vehicle and a possible role for copper in the response. A temperature effect similar to that seen with nonsteroidalantiinflammatory drugs (NSAIDs) was observed, 55° produced observable antinociception, however, at a surface temperature of 58°C no drug effect was seen. Non-aqeous vehicles such as peanut oil increased the potency of THC-7-oic acid. Finally, the substitution of purified water for tap water reduced,the drug response which could be partially restored by adding copper to the purified drinking water. An increase in the inhibitory effect when copper was added was also seenin vitro in a cell culture model where the acid reduced prostaglandin synthesis induced by THC. Our findings suggest that THC-7-oic acid probably acts by mechanisms similar to the NSAIDs and that the above mentioned experimental conditions can greatly influence the outcome of studies with this agent.


Copper Cell Culture Drinking Water Surface Temperature Prostaglandin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    S. Burstein, J. Rosenfeld and T. Wittstruck,Isolation and characterization of two major urinary metabolites of Δ. Science176, 422 (1972).PubMedGoogle Scholar
  2. [2]
    M. Nordquist, J. E. Lindgren and S. Agurell,Acidic metabolites of Δ 1 isolated from rabbit urine. J. Pharm. Pharmacol.31, 231–237 (1979).PubMedGoogle Scholar
  3. [3]
    D. J. Harvey and W. D. M. Paton,Identification of in vivo liver metabolites of Δ 6 produced in the mouse. Drug Metab. Dispos.,8, 178–186 (1980).PubMedGoogle Scholar
  4. [4]
    M. E. Wall and M. Perez-Reyes,The metabolism of Δ 9 and related cannabinoids in man. J. Clin. Pharmacol.21, 178S-189S (1981).PubMedGoogle Scholar
  5. [5]
    R. Mechoulam, Z. Ben-Zvi, S. Agurell, I. M. Nilsson, J. L. G. Nilsson, H. Edery and Y. Grunfeld,Δ 6 acid, an urinary Δ 6 metabolite: isolation and synthesis. Exper.29 1193–1195 (1973).Google Scholar
  6. [6]
    K. Watanabe, I. Namamoto, K. Oguri and H. Noshimura,Comparison in mice of pharmacological effects of Δ 8 and its metabolites oxidized at the 11-position. Eur. J. Pharmacol.63, 1–6 (1980).PubMedGoogle Scholar
  7. [7]
    S. H. Burstein, K. Hull, S. A. Hunter and V. Latham,Cannabinoids and pain responses: a possible role for prostaglandins. FASEB J.2, 3022–3026 (1988).PubMedGoogle Scholar
  8. [8]
    S. Burstein, S. A. Hunter, V. Latham, and L. Renzulli,Prostaglandin and Canabis XVI. Antagonism of Δ 1 action by its metabolites. Biochem. Pharmacol35, 2553–2558 (1986).PubMedGoogle Scholar
  9. [9]
    W. L. Dewey,Cannabinoid pharmacology. Pharmacol. Revs.38, 151–178 (1986).Google Scholar
  10. [10]
    S. H. Burstein, C. A. Audette, S. A. Doyle, K. Hull, S. A. Hunter and V. Latham,Antagonism to the actions of PAF by a non-psychoactve cannabinoid. J. Pharmacol. Exper. Therap.,251, 531–535 (1989).Google Scholar
  11. [11]
    D. P. Tashkin, B. J. Shapiro and I. M. Frank,Acute pulmonary physiologic effects of smoked marijunana and oral Δ 9 in healthy young men. N. Engl. J. Med.289, 336–341 (1973).PubMedGoogle Scholar
  12. [12]
    S. J. Williams, J. P. R. Hartley and J. D. P. Graham,Bronchodilator effect of Δ 1 administered by aerosol to asthmatic patients. Thorax31, 720–723 (1976).PubMedGoogle Scholar
  13. [13]
    I. Kitchen and P. G. Green,Differential effects of DFP poisoning and its treatment on opioid antinociception in the mouse. Life Sci.33, 669–672 (1983).PubMedGoogle Scholar
  14. [14]
    W. Calhoun, J. Chang and R. P. Carlson,Effect of selected antiinflammatory agents and other drugs on zymosan, arachidonic acid, PAF and carrageenan induced paw edema in the mouse. Agents and Actions21, 306–309 (1987).PubMedGoogle Scholar
  15. [15]
    J. M. Hall and C. Hallett,A simple precise method for measuring rodent paw volume. J. Pharm. Pharmacol.27, 623 (1987).Google Scholar
  16. [16]
    S. Burstein, S. A. Hunter, C. Sedor and S. Shulman,Prostaglandins and Cannabis IX. Stimulation of prostaglandin E 2 synthesis in human lung fibroblasts by Δ 1. Biochem. Pharmac.31, 2361–2365 (1982).Google Scholar
  17. [17]
    R. W. Bryant, S. J. Feimonk, S. J. Makhega and J. M. Bailey,Lipid metabolism in cultured cells. J. Biol. Chem.253, 8134–8140 (1978).PubMedGoogle Scholar
  18. [18]
    S. I. Ankier,New hot plate tests to quantify antinociceptive and narcotic antagonist activities. Eur. J. Pharmacol.27, 1–4 (1974).PubMedGoogle Scholar
  19. [19]
    D. Luttinger,Determination of antinociceptive efficacy of drugs in mice using different water temperatures in a tail-immersion test. J. Pharmacol. Meth.13, 351–357 (1985).Google Scholar
  20. [20]
    R. D. Sophia, S. D. Nalepa, J. J. Harakal and H. B. Vassar,Anti-edema and analgesic properties of Δ 9. J. Pharmacol. Exper. Therap.186, 646–655 (1973).Google Scholar
  21. [21]
    S. Chakrabarti and F. M. Belpaire,Bioavailability of phenytoin in lipid containing dosage forms in rats. J. Pharm. Pharmac.30, 330–331 (1978).Google Scholar
  22. [22]
    K. J. Palin, C. G. Wilson, S. S. Davis and A. J. Phillips,The effect of oils on the lymphatic absorption of DDT.ibid.34, 707–710 (1982).Google Scholar
  23. [23]
    K. J. Palin and C. G. Wilson,The effect of different oils on the absorption of probucol in the rat.ibid.36, 641–643 (1984).Google Scholar
  24. [24]
    J. R. J. Sorenson,Development of copper complexes for potential therapeutic use. InTrace elements in the pathogenesis and treatment of inflammation. (Eds. K. D. Rainsford, K. Brune and M. W. Whitehouse) pp. 305–325., Birkhauser, Basel 1981.Google Scholar
  25. [25]
    J. J. Feigenbaum, S. A. Richmond, Y. Weisman and R. Mechoulam,Inhibition of cisplatin-induced emesis, in the pigeon by a non-psychotropic synthetic cannabinoid. Eur. J. Pharmacol.169, 159–165 (1989).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1990

Authors and Affiliations

  • S. A. Doyle
    • 1
  • S. H. Burstein
    • 1
  • W. L. Dewey
    • 2
  • S. P. Welch
    • 2
  1. 1.Department of BiochemistryUniversity of Massachusetts Medical CenterWorcesterUSA
  2. 2.Department of Pharmacology and ToxicologyMedical College of VirginiaRichmondUSA

Personalised recommendations